Sexual Functioning After Primary Treatment of Ovarian Cancer
The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer.
How common are sexual problems after treatment for ovarian cancer?
- What factors make women more likely to have sexual problems after treatment for ovarian cancer?
- What happens to sexual functioning over the first 12 months after treatment? ie.
Does it get better or worse?
• Does referral to a specialized sexual health clinic help?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months
- Women must have no clinical evidence of disease
- At least 18 years of age
- English speaking
- Able to participate in the informed consent process
- Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC.
Exclusion Criteria:
- Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment
- Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination
- Women with borderline (low malignant potential) ovarian cancers
- Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic
- Women with a history of prior whole pelvic radiation
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
1
FSFI score <= 26
|
will be offered referral to the Sexual Health Clinic (SHC) at MSKCC for evaluation and possible treatment.
The effectiveness and compliance of the intervention offered at the SHC will be assessed at approximately 3, 6 and 12 months using the FSFI, SAQ, CES-D, MSC and IES.
At each evaluation they will complete a Health Surveillance Form (HSF).
They will have completed the study at 12 months after entering the study or at the time they have evidence of recurrent disease requiring treatment
Those women who have a FSFI score > 26 will be reassessed at approximately 3, 6 and 12 months.
They will complete the FSFI, SAQ, CES-D, IES, MSC and HSF at each assessment.
They will be followed out until 12 months after entering the study or until they have evidence of recurrent disease.
|
|
2
FSFI score >26
|
will be offered referral to the Sexual Health Clinic (SHC) at MSKCC for evaluation and possible treatment.
The effectiveness and compliance of the intervention offered at the SHC will be assessed at approximately 3, 6 and 12 months using the FSFI, SAQ, CES-D, MSC and IES.
At each evaluation they will complete a Health Surveillance Form (HSF).
They will have completed the study at 12 months after entering the study or at the time they have evidence of recurrent disease requiring treatment
Those women who have a FSFI score > 26 will be reassessed at approximately 3, 6 and 12 months.
They will complete the FSFI, SAQ, CES-D, IES, MSC and HSF at each assessment.
They will be followed out until 12 months after entering the study or until they have evidence of recurrent disease.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease.
Time Frame: conclusion of study
|
conclusion of study
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To study the natural history of sexual functioning in women after primary treatment of ovarian cancer by using the FSFI at approximately 3, 6 and 12 months.
Time Frame: conclusion of study
|
conclusion of study
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Elizabeth Jewell, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms by Histologic Type
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Genital Neoplasms, Female
- Endocrine System Diseases
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Endocrine Gland Neoplasms
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
Other Study ID Numbers
Other Study ID Numbers
- 04-124
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.